|
|
Article: ALLERGAN LIGAND RETINOID THERAPEUTICS INC. SUBSCRIPTION OFFERING DECLARED EFFECTIVE BY SEC
- Article from:
- PR Newswire
- Article date:
- May 5, 1995
CopyrightCOPYRIGHT 1995 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN DIEGO and IRVINE, Calif., May 5 /PRNewswire/ -- Ligand Pharmaceuticals Incorporated (Nasdaq-NNM: LGND) and Allergan Inc. (NYSE: AGN) announced today that the Securities and Exchange Commission declared effective the registration statement filed by Ligand and Allergan Ligand Retinoid Therapeutics, Inc. (ALRT) relating to a rights offering to stockholders of Ligand and stockholders of Allergan. Rights issued in the offering will be distributed to stockholders of Ligand and stockholders of Allergan of record at the close of business on May 5, 1995 (the "Record Date") and will trade on the Nasdaq National Market commencing on May 8, 1995 through 4 p.m., New York City time ...